title: Heterogeneity of bronchiolitis obliterans organizing pneumonia.
abstract: Reports of the characterization and understanding of bronchiolitis obliterans organizing pneumonia (BOOP) have continued at an accelerated rate for several years. The radiographic and high-resolution CT features of BOOP continue to be documented. There have been new insights into the pathogenesis of BOOP. An animal model has been developed. Video-assisted thoracoscopic biopsy has become a standard for confirming the diagnosis. Childhood BOOP has been described in several reports. Idiopathic BOOP continues to be the most common type; however, a variety of clinical settings such as inhalation of mold spores and associated disorders such as renal transplantation continue to be described. This paper provides an update of advances in the pathogenesis, radiographic features, clinical course, and categorization of the heterogeneity of BOOP.
authors.affiliation: New England Baptist Hospital, Boston, MA 02120, USA.
authors.forename: G R
authors.initials: GR
authors.lastname: Epler
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D004396:Coloring Agents / Q000009:adverse effects; D018549:Cryptogenic Organizing Pneumonia / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects; D016040:Lung Transplantation / Q000009:adverse effects; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D014057:Tomography, X-Ray Computed
chemical_list: D000900:Anti-Bacterial Agents; D004396:Coloring Agents; D011241:Prednisone